Chalise, P., Walsh, R. M., Ambrose, J., Jack, J. L., Eades, A. E., Bye, B. A., . . . VanSaun, M. N. Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationChalise, Prabhakar, et al. Depletion of Tumor-derived CXCL5 Improves T Cell Infiltration and Anti-PD-1 Therapy Response in an Obese Model of Pancreatic Cancer. BMJ Publishing Group.
MLA (9th ed.) CitationChalise, Prabhakar, et al. Depletion of Tumor-derived CXCL5 Improves T Cell Infiltration and Anti-PD-1 Therapy Response in an Obese Model of Pancreatic Cancer. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.